Hormone Receptor Positive Tumor Active Not Recruiting Phase 2 Trials for Fulvestrant (DB00947)

IndicationStatusPhase
DBCOND0075370 (Hormone Receptor Positive Tumor)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02675231A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast CancerTreatment
NCT02894398Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or FulvestrantTreatment